光疗改变早产儿高胆红素血症血浆代谢物谱
该研究纳入92例早产儿,其中需光疗的极早产儿27例和中/晚期早产儿33例,在光疗前、光疗后24小时及部分48小时采集血浆,用超高效液相色谱串联质谱检测代谢物。发现光疗对血浆代谢物谱的影响大于胎龄,主要涉及膜脂代谢、一碳代谢、肌酸生物合成和少突胶质细胞分化等通路。
要点
- 光疗对早产儿血浆代谢物谱的影响大于胎龄因素。
- 光疗影响膜脂代谢、一碳代谢、肌酸生物合成和少突胶质细胞分化通路。
- 极早产儿开始光疗时总血清胆红素水平低于中/晚期早产儿(7.3±1.4 vs 9.9±1.9 mg/dL,P<.01)。
核心结论
- 光疗对早产儿高胆红素血症血浆代谢物谱的影响大于胎龄,涉及脂质和一碳代谢、能量生物合成及少突胶质细胞分化相关通路。
研究设计与样本
- 前瞻性纳入92例早产儿,其中需光疗的极早产儿27例(胎龄28+0至31+6周)和中/晚期早产儿33例(胎龄32+0至35+6周)。
- 在光疗前和光疗开始后24小时采集血浆样本,并在随机选择的30例亚组(极早产儿15例、中/晚期早产儿15例)中于光疗开始后48小时额外采集样本。
- 采用超高效液相色谱串联质谱测定代谢物谱,使用两因素协方差分析(调整总血清胆红素水平,错误发现率q值<0.05)识别胎龄组和时间点间差异代谢物,并通过通路过代表分析识别受影响通路。
主要发现
- 极早产儿开始光疗时总血清胆红素水平低于中/晚期早产儿(7.3±1.4 vs 9.9±1.9 mg/dL,P<.01)。
- 共鉴定出664种代谢物对光疗效应显著、191种对胎龄显著、46种对胎龄×光疗交互作用显著(错误发现率q值<0.05)。
- 光疗持续时间越长平均效应量越大(光疗后24小时d=0.36;光疗后48小时d=0.43)。
- 光疗影响的主要通路包括膜脂代谢、一碳代谢、肌酸生物合成和少突胶质细胞分化。
关键数值与推荐
- 光疗效应显著代谢物664种,胎龄显著代谢物191种,胎龄×光疗交互作用显著代谢物46种(错误发现率q值<0.05)。
- 光疗后24小时平均效应量d=0.36,光疗后48小时平均效应量d=0.43。
- 极早产儿光疗开始时总血清胆红素均值±标准差为7.3±1.4 mg/dL,中/晚期早产儿为9.9±1.9 mg/dL(P<.01)。
临床怎么用
- 儿科医生应关注光疗对早产儿代谢通路的广泛影响,尤其是脂质代谢、一碳代谢和少突胶质细胞分化相关通路。
- 极早产儿在较低总血清胆红素水平即开始光疗,临床决策需结合胎龄评估光疗阈值。
- 光疗对代谢物谱的影响随光疗时间延长而增大,需监测较长疗程光疗的代谢效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the effects of gestational age (GA) and phototherapy on the plasma metabolite profile of preterm infants with neonatal hyperbilirubinemia (NHB). STUDY DESIGN: From a cohort of prospectively enrolled infants born preterm (n = 92), plasma samples of very preterm (VPT; GA, 28 + 0 to 31 + 6 weeks, n = 27) and moderate/late preterm (M/LPT; GA, 32 + 0 to 35 + 6 weeks, n = 33) infants requiring phototherapy for NHB were collected prior to the initiation of phototherapy and 24 hours after starting phototherapy. An additional sample was collected 48 hours after starting phototherapy in a randomly selected subset (n = 30; VPT n = 15; M/LPT n = 15). Metabolite profiles were determined using ultraperformance liquid chromatography tandem mass spectroscopy. Two-way ANCOVA was used to identify metabolites that differed between GA groups and timepoints after adjusting for total serum bilirubin levels (false discovery rate q-value < 0.05). Top impacted pathways were identified using pathway over-representation analysis. RESULTS: Phototherapy was initiated at lower total serum bilirubin (mean ± SD mg/dL) levels in VPT compared with M/LPT infants (7.3 ± 1.4 vs 9.9 ± 1.9, P < .01). We identified 664 metabolites that were significant for a phototherapy effect, 191 metabolites significant for GA, and 46 metabolites significant for GA × phototherapy interaction (false discovery rate q-value < 0.05). Longer duration phototherapy had a larger mean effect size (24 hours postphototherapy: d = 0.36; 48 hours postphototherapy: d = 0.43). Top pathways affected by phototherapy included membrane lipid metabolism, one-carbon metabolism, creatine biosynthesis, and oligodendrocyte differentiation. CONCLUSION: Phototherapy alters the plasma metabolite profile more than GA in preterm infants with NHB, affecting pathways related to lipid and one-carbon metabolism, energy biosynthesis, and oligodendrocyte differentiation.
引用
- Satrom KM, Wang J, Lock EF, et al. Phototherapy Alters the Plasma Metabolite Profile in Infants Born Preterm with Hyperbilirubinemia. J Pediatr. 2024. PMID: 38945444. doi:10.1016/j.jpeds.2024.114175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。